{"pmid":32360301,"pmcid":"PMC7187831","title":"A proposal for the return to routine endoscopy during the COVID-19 pandemic.","text":["A proposal for the return to routine endoscopy during the COVID-19 pandemic.","In response to the COVID-19 pandemic, many jurisdictions and gastroenterological societies around the world have suspended nonurgent endoscopy. Subject to country-specific variability, it is projected that with current mitigation measures in place, the peak incidence of active COVID-19 infections may be delayed by over 6 months. Although this aims to prevent the overburdening of healthcare systems, prolonged deferral of elective endoscopy will become unsustainable. Herein, we propose that by incorporating readily available point-of-care tests and conducting accurate clinical risk assessments, a safe and timely return to elective endoscopy is feasible. Our algorithm not only focuses on the safety of patients and healthcare workers, but also assists in rationalizing the use of invaluable resources such as personal protective equipment.","Gastrointest Endosc","Gupta, Sunil","Shahidi, Neal","Gilroy, Nicole","Rex, Douglas K","Burgess, Nicholas G","Bourke, Michael J","32360301"],"abstract":["In response to the COVID-19 pandemic, many jurisdictions and gastroenterological societies around the world have suspended nonurgent endoscopy. Subject to country-specific variability, it is projected that with current mitigation measures in place, the peak incidence of active COVID-19 infections may be delayed by over 6 months. Although this aims to prevent the overburdening of healthcare systems, prolonged deferral of elective endoscopy will become unsustainable. Herein, we propose that by incorporating readily available point-of-care tests and conducting accurate clinical risk assessments, a safe and timely return to elective endoscopy is feasible. Our algorithm not only focuses on the safety of patients and healthcare workers, but also assists in rationalizing the use of invaluable resources such as personal protective equipment."],"journal":"Gastrointest Endosc","authors":["Gupta, Sunil","Shahidi, Neal","Gilroy, Nicole","Rex, Douglas K","Burgess, Nicholas G","Bourke, Michael J"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32360301","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.gie.2020.04.050","keywords":["colonoscopy","coronavirus","endoscopy","pandemic","sars-cov-2"],"topics":["Prevention"],"weight":1,"_version_":1666138495903596544,"score":9.490897,"similar":[{"pmid":32241897,"title":"Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements).","text":["Practice of endoscopy during COVID-19 pandemic: position statements of the Asian Pacific Society for Digestive Endoscopy (APSDE-COVID statements).","Coronavirus-19 (COVID-19) caused by SARS-CoV-2 has become a global pandemic. Risk of transmission may occur during endoscopy and the goal is to prevent infection among healthcare professionals while providing essential services to patients. Asia was the first continent to have a COVID-19 outbreak, and this position statement of the Asian Pacific Society for Digestive Endoscopy shares our successful experience in maintaining safe and high-quality endoscopy practice at a time when resources are limited. Sixteen experts from key societies of digestive endoscopy in Asia were invited to develop position statements, including patient triage and risk assessment before endoscopy, resource prioritisation and allocation, regular monitoring of personal protective equipment, infection control measures, protective device training and implementation of a strategy for stepwise resumption of endoscopy services after control of the COVID-19 outbreak.","Gut","Chiu, Philip Wai Yan","Ng, Siew C","Inoue, Haruhiro","Reddy, D Nageshwar","Ling Hu, Enqiang","Cho, Joo Young","Ho, Lawrence Ky","Hewett, David G","Chiu, Han-Mo","Rerknimitr, Rungsun","Wang, Hsiu-Po","Ho, Shiaw Hooi","Seo, Dong Wan","Goh, Khean-Lee","Tajiri, Hisao","Kitano, Seigo","Chan, Francis K L","32241897"],"abstract":["Coronavirus-19 (COVID-19) caused by SARS-CoV-2 has become a global pandemic. Risk of transmission may occur during endoscopy and the goal is to prevent infection among healthcare professionals while providing essential services to patients. Asia was the first continent to have a COVID-19 outbreak, and this position statement of the Asian Pacific Society for Digestive Endoscopy shares our successful experience in maintaining safe and high-quality endoscopy practice at a time when resources are limited. Sixteen experts from key societies of digestive endoscopy in Asia were invited to develop position statements, including patient triage and risk assessment before endoscopy, resource prioritisation and allocation, regular monitoring of personal protective equipment, infection control measures, protective device training and implementation of a strategy for stepwise resumption of endoscopy services after control of the COVID-19 outbreak."],"journal":"Gut","authors":["Chiu, Philip Wai Yan","Ng, Siew C","Inoue, Haruhiro","Reddy, D Nageshwar","Ling Hu, Enqiang","Cho, Joo Young","Ho, Lawrence Ky","Hewett, David G","Chiu, Han-Mo","Rerknimitr, Rungsun","Wang, Hsiu-Po","Ho, Shiaw Hooi","Seo, Dong Wan","Goh, Khean-Lee","Tajiri, Hisao","Kitano, Seigo","Chan, Francis K L"],"date":"2020-04-04T11:00:00Z","year":2020,"_id":"32241897","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1136/gutjnl-2020-321185","keywords":["clinical decision making","endoscopy"],"topics":["Prevention"],"weight":1,"_version_":1666138492110897152,"score":240.29019},{"pmid":32281689,"title":"COVID-19 and gastrointestinal endoscopies: current insights and emergent strategies.","text":["COVID-19 and gastrointestinal endoscopies: current insights and emergent strategies.","A new coronavirus emerged in December 2019 in Wuhan city of China, named as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and disease was called as coronavirus disease-2019 (COVID-19). The infection due to this virus spread exponentially throughout China and then spread across >205 nations, including the United States (US). Gastrointestinal (GI) endoscopies are routinely performed in the US and globally. Previous reports of isolated infection outbreaks were reported with endoscopes acting as potential vectors. While multidrug-resistant organisms have been reported to be spread by endoscopes, few cases of viruses such as Hepatitis B and C are noted in the literature. COVID-19 predominately spread by droplet transmission, although recent evidence showed that shedding in feces and feco-oral transmission could also be possible. It is unclear if COVID-19 could be transmitted by endoscopes, but it could theoretically happen due to contact with mucous membranes and body fluids. GI endoscopies involve close contact with oral and colonic contents exposing endoscopy staff to respiratory and oropharyngeal secretions. This can increase the risk of contamination and contribute to virus transmission. Given these risks, all major GI societies have called for rescheduling elective non-urgent procedures and perform only emergent or urgent based on the clinical need. Furthermore, pre-screening of all individuals prior to endoscopy is recommended. This article focuses on the risk of COVID-19 transmission by GI shedding, the potential role of endoscopes as a vector of this novel virus including transmission during endoscopies and prevention strategies including deferral of elective non-urgent endoscopy procedures.","Dig Endosc","Perisetti, Abhilash","Gajendran, Mahesh","Boregowda, Umesha","Bansal, Pardeep","Goyal, Hemant","32281689"],"abstract":["A new coronavirus emerged in December 2019 in Wuhan city of China, named as the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), and disease was called as coronavirus disease-2019 (COVID-19). The infection due to this virus spread exponentially throughout China and then spread across >205 nations, including the United States (US). Gastrointestinal (GI) endoscopies are routinely performed in the US and globally. Previous reports of isolated infection outbreaks were reported with endoscopes acting as potential vectors. While multidrug-resistant organisms have been reported to be spread by endoscopes, few cases of viruses such as Hepatitis B and C are noted in the literature. COVID-19 predominately spread by droplet transmission, although recent evidence showed that shedding in feces and feco-oral transmission could also be possible. It is unclear if COVID-19 could be transmitted by endoscopes, but it could theoretically happen due to contact with mucous membranes and body fluids. GI endoscopies involve close contact with oral and colonic contents exposing endoscopy staff to respiratory and oropharyngeal secretions. This can increase the risk of contamination and contribute to virus transmission. Given these risks, all major GI societies have called for rescheduling elective non-urgent procedures and perform only emergent or urgent based on the clinical need. Furthermore, pre-screening of all individuals prior to endoscopy is recommended. This article focuses on the risk of COVID-19 transmission by GI shedding, the potential role of endoscopes as a vector of this novel virus including transmission during endoscopies and prevention strategies including deferral of elective non-urgent endoscopy procedures."],"journal":"Dig Endosc","authors":["Perisetti, Abhilash","Gajendran, Mahesh","Boregowda, Umesha","Bansal, Pardeep","Goyal, Hemant"],"date":"2020-04-14T11:00:00Z","year":2020,"_id":"32281689","source":"PubMed","week":"202016|Apr 13 - Apr 19","doi":"10.1111/den.13693","keywords":["covid-19","coronavirus","sars-cov-2","endoscopy","pandemic"],"locations":["Wuhan","China","China","United States","US","US"],"countries":["United States","China"],"countries_codes":["USA|United States","CHN|China"],"topics":["Transmission","Prevention"],"weight":1,"_version_":1666138491428274177,"score":238.21747},{"pmid":32335946,"title":"Gastrointestinal endoscopy in the era of the acute pandemic of COVID-19: Recommendations by Japan Gastroenterological Endoscopy Society (Issued on April 9(th) , 2020.).","text":["Gastrointestinal endoscopy in the era of the acute pandemic of COVID-19: Recommendations by Japan Gastroenterological Endoscopy Society (Issued on April 9(th) , 2020.).","All gastrointestinal endoscopic procedures have a high risk of aerosol contamination of the coronavirus disease 2019 (COVID-19) to endoscopists, nurses, and healthcare assistants. Given the current pandemic situation of COVID-19, the Japan Gastroenterological Endoscopy Society (JGES) issued the recommendation for gastrointestinal (GI) endoscopy based on the status of COVID-19 as of April 9th, 2020, in Japan; 1) indications for GI endoscopy in the pandemic of COVID-19, 2) practical protective equipment for medical personals depending on the risk for COVID-19, 3) preprocedural management, such as pharyngeal local anesthesia using lidocaine spray which has a potential to generate the aerosols, 4) ideal settings of the endoscopy room including the numbers of the staff and the patients, 5) postprocedural management, such as undressing and follow-up of the patients, as well as the involved staff, were documented to fit the practical scenarios in GI endoscopy, with the available data in Japan and the world. We believe that certain measures will prevent further spread of COVID-19.","Dig Endosc","Irisawa, Atsushi","Furuta, Takahisa","Matsumoto, Takayuki","Kawai, Takashi","Inaba, Tomoki","Kanno, Atsushi","Katanuma, Akio","Kawahara, Yoshiro","Matsuda, Koji","Mizukami, Kazuhiro","Otsuka, Takao","Yasuda, Ichiro","Tanaka, Shinji","Fujimoto, Kazuma","Fukuda, Shinsaku","Iishi, Hiroyasu","Igarashi, Yoshinori","Inui, Kazuo","Ueki, Toshiharu","Ogata, Haruhiko","Kato, Mototsugu","Shiotani, Akiko","Higuchi, Kazuhide","Fujita, Naotaka","Murakami, Kazunari","Yamamoto, Hironori","Ito, Tohru","Okazaki, Kazuichi","Kitagawa, Yuko","Mine, Tetsuya","Tajiri, Hisao","Inoue, Haruhiro","32335946"],"abstract":["All gastrointestinal endoscopic procedures have a high risk of aerosol contamination of the coronavirus disease 2019 (COVID-19) to endoscopists, nurses, and healthcare assistants. Given the current pandemic situation of COVID-19, the Japan Gastroenterological Endoscopy Society (JGES) issued the recommendation for gastrointestinal (GI) endoscopy based on the status of COVID-19 as of April 9th, 2020, in Japan; 1) indications for GI endoscopy in the pandemic of COVID-19, 2) practical protective equipment for medical personals depending on the risk for COVID-19, 3) preprocedural management, such as pharyngeal local anesthesia using lidocaine spray which has a potential to generate the aerosols, 4) ideal settings of the endoscopy room including the numbers of the staff and the patients, 5) postprocedural management, such as undressing and follow-up of the patients, as well as the involved staff, were documented to fit the practical scenarios in GI endoscopy, with the available data in Japan and the world. We believe that certain measures will prevent further spread of COVID-19."],"journal":"Dig Endosc","authors":["Irisawa, Atsushi","Furuta, Takahisa","Matsumoto, Takayuki","Kawai, Takashi","Inaba, Tomoki","Kanno, Atsushi","Katanuma, Akio","Kawahara, Yoshiro","Matsuda, Koji","Mizukami, Kazuhiro","Otsuka, Takao","Yasuda, Ichiro","Tanaka, Shinji","Fujimoto, Kazuma","Fukuda, Shinsaku","Iishi, Hiroyasu","Igarashi, Yoshinori","Inui, Kazuo","Ueki, Toshiharu","Ogata, Haruhiko","Kato, Mototsugu","Shiotani, Akiko","Higuchi, Kazuhide","Fujita, Naotaka","Murakami, Kazunari","Yamamoto, Hironori","Ito, Tohru","Okazaki, Kazuichi","Kitagawa, Yuko","Mine, Tetsuya","Tajiri, Hisao","Inoue, Haruhiro"],"date":"2020-04-27T11:00:00Z","year":2020,"_id":"32335946","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1111/den.13703","keywords":["covid-19","corona virus","gastrointestinal endoscopy","personal protective equipment"],"locations":["Japan","anesthesia","Japan"],"countries":["Japan"],"countries_codes":["JPN|Japan"],"topics":["Prevention"],"weight":1,"_version_":1666138494093754371,"score":231.79486},{"pmid":32233034,"title":"Overview of guidance for endoscopy during the coronavirus disease 2019 pandemic.","text":["Overview of guidance for endoscopy during the coronavirus disease 2019 pandemic.","From its beginning in December 2019, the coronavirus disease 2019 outbreak has spread globally from Wuhan and is now declared a pandemic by the World Health Organization. The sheer scale and severity of this pandemic is unprecedented in the modern era. Although primarily a respiratory tract infection transmitted by direct contact and droplets, during aerosol-generating procedures, there is a possibility of airborne transmission. In addition, emerging evidence suggests possible fecal-oral spread of the virus. Clinical departments that perform endoscopy are faced with daunting challenges during this pandemic. To date, multiple position statements and guidelines have been issued by various professional organizations to recommend practices in endoscopic procedures. This article aims to summarize and discuss available evidence for these practices, to provide guidance for endoscopy to enhance patient safety, avoid nosocomial outbreaks, protect healthcare personnel, and ensure rational use of personal protective equipment. Responses adapted to national recommendations and local infection control guidelines and tailored to the availability of medical resources are imminently needed to fight the coronavirus disease 2019 pandemic.","J Gastroenterol Hepatol","Lui, Rashid N","Wong, Sunny H","Sanchez-Luna, Sergio A","Pellino, Gianluca","Bollipo, Steven","Wong, Mei-Yin","Chiu, Philip W Y","Sung, Joseph J Y","32233034"],"abstract":["From its beginning in December 2019, the coronavirus disease 2019 outbreak has spread globally from Wuhan and is now declared a pandemic by the World Health Organization. The sheer scale and severity of this pandemic is unprecedented in the modern era. Although primarily a respiratory tract infection transmitted by direct contact and droplets, during aerosol-generating procedures, there is a possibility of airborne transmission. In addition, emerging evidence suggests possible fecal-oral spread of the virus. Clinical departments that perform endoscopy are faced with daunting challenges during this pandemic. To date, multiple position statements and guidelines have been issued by various professional organizations to recommend practices in endoscopic procedures. This article aims to summarize and discuss available evidence for these practices, to provide guidance for endoscopy to enhance patient safety, avoid nosocomial outbreaks, protect healthcare personnel, and ensure rational use of personal protective equipment. Responses adapted to national recommendations and local infection control guidelines and tailored to the availability of medical resources are imminently needed to fight the coronavirus disease 2019 pandemic."],"journal":"J Gastroenterol Hepatol","authors":["Lui, Rashid N","Wong, Sunny H","Sanchez-Luna, Sergio A","Pellino, Gianluca","Bollipo, Steven","Wong, Mei-Yin","Chiu, Philip W Y","Sung, Joseph J Y"],"date":"2020-04-02T11:00:00Z","year":2020,"_id":"32233034","source":"PubMed","week":"202014|Mar 30 - Apr 05","doi":"10.1111/jgh.15053","keywords":["covid-19","coronavirus","endoscopy","infection prevention and control","ppe","pandemic","personal protective equipment","sars-cov-2"],"locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Prevention"],"weight":1,"_version_":1666138492210511875,"score":228.2681},{"pmid":32360302,"title":"COVID-19 polymerase chain reaction testing before endoscopy: an economic analysis.","text":["COVID-19 polymerase chain reaction testing before endoscopy: an economic analysis.","BACKGROUND AND AIMS: The COVID-19 pandemic has limited endoscopy utilization, causing significant health and economic losses. We aim to model the impact of PCR testing into resuming endoscopy practice. METHODS: We performed a retrospective review of endoscopy utilization during the COVID-19 pandemic for a baseline reference. A computer model compared 3 approaches-Strategy 1: endoscopy for urgent indications only; Strategy 2: testing for semi-urgent indications; and Strategy 3: testing all patients. Analysis was made under current COVID-19 prevalence, and projected prevalence of 5% and 10%. Primary outcomes were number of procedures performed/cancelled. Secondary outcomes were direct costs, reimbursement, personal protective equipment used and personnel infected. Disease prevalence, testing accuracy, and costs were obtained from literature. RESULTS: During the COVID-19 pandemic, endoscopy volume was 12.7% of expected. Strategy 2 and 3 were safe and effective interventions to resume endoscopy in semi-urgent and elective cases. Investing 22USD and 105USD in testing per patient allowed completing 19.4% and 95.3% of baseline endoscopies respectively. False negative results were seen after testing 4,700 patients (or 3 months applying Strategy 2 in our practice). Implementing PCR testing over 1 week in United States would require 13 and 64 million USD, with a return of 165 and 767 million USD to providers, leaving 65 and 325 health care workers infected. CONCLUSION: PCR testing is an effective strategy to restart endoscopic practice in United States. PCR screening should be implemented during the second phase of the pandemic, once the healthcare system is able to test and isolate all suspected COVID-19 cases.","Gastrointest Endosc","Corral, Juan E","Hoogenboom, Sanne A","Kroner, Paul T","Vazquez-Roque, Maria I","Picco, Michael F","Farraye, Francis A","Wallace, Michael B","32360302"],"abstract":["BACKGROUND AND AIMS: The COVID-19 pandemic has limited endoscopy utilization, causing significant health and economic losses. We aim to model the impact of PCR testing into resuming endoscopy practice. METHODS: We performed a retrospective review of endoscopy utilization during the COVID-19 pandemic for a baseline reference. A computer model compared 3 approaches-Strategy 1: endoscopy for urgent indications only; Strategy 2: testing for semi-urgent indications; and Strategy 3: testing all patients. Analysis was made under current COVID-19 prevalence, and projected prevalence of 5% and 10%. Primary outcomes were number of procedures performed/cancelled. Secondary outcomes were direct costs, reimbursement, personal protective equipment used and personnel infected. Disease prevalence, testing accuracy, and costs were obtained from literature. RESULTS: During the COVID-19 pandemic, endoscopy volume was 12.7% of expected. Strategy 2 and 3 were safe and effective interventions to resume endoscopy in semi-urgent and elective cases. Investing 22USD and 105USD in testing per patient allowed completing 19.4% and 95.3% of baseline endoscopies respectively. False negative results were seen after testing 4,700 patients (or 3 months applying Strategy 2 in our practice). Implementing PCR testing over 1 week in United States would require 13 and 64 million USD, with a return of 165 and 767 million USD to providers, leaving 65 and 325 health care workers infected. CONCLUSION: PCR testing is an effective strategy to restart endoscopic practice in United States. PCR screening should be implemented during the second phase of the pandemic, once the healthcare system is able to test and isolate all suspected COVID-19 cases."],"journal":"Gastrointest Endosc","authors":["Corral, Juan E","Hoogenboom, Sanne A","Kroner, Paul T","Vazquez-Roque, Maria I","Picco, Michael F","Farraye, Francis A","Wallace, Michael B"],"date":"2020-05-04T11:00:00Z","year":2020,"_id":"32360302","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1016/j.gie.2020.04.049","keywords":["covid-19","sars-cov-2 virus","outcome research","screening"],"locations":["United States","United States"],"countries":["United States"],"countries_codes":["USA|United States"],"topics":["Prevention"],"weight":1,"_version_":1666138495939248128,"score":217.8361}]}